Sun Pharmaceutical Industries Ltd.

Indian pharmaceutical stocks declined after US President Donald Trump's move to impose 100% import tariffs on pharmaceutical drugs from October 1.

Sun Pharmaceutical Industries is currently trading at Rs. 1579.35, down by 48.65 points or 2.99% from its previous closing of Rs. 1628.00 on the BSE. The scrip opened at Rs. 1590.60 and has touched a high and low of Rs. 1602.90 and Rs. 1547.25 respectively. So far 246150 shares were traded on the counter. 

Lupin is currently trading at Rs. 1927.00, down by 34.45 points or 1.76% from its previous closing of Rs. 1961.45 on the BSE. The scrip opened at Rs. 1923.30 and has touched a high and low of Rs. 1950.65 and Rs. 1912.90 respectively. So far 20214 shares were traded on the counter.

Dr. Reddy's Laboratories is currently trading at Rs. 1255.25, down by 19.55 points or 1.53% from its previous closing of Rs. 1274.80 on the BSE. The scrip opened at Rs. 1248.10 and has touched a high and low of Rs. 1277.95 and Rs. 1245.30 respectively. So far 75324 shares were traded on the counter.

US President Donald Trump has imposed 100% tariffs on branded and patented pharmaceutical exports. The move has rattled Indian pharma stocks, even though most companies earn from US markets by selling generic drugs. On Indian pharmaceutical exports front, the US represents the primary market, comprising approximately 35% of total exports, with a value reaching about $10 billion in FY25.